1. Home
  2. QTRX vs DERM Comparison

QTRX vs DERM Comparison

Compare QTRX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.37

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

DERM

Journey Medical Corporation

HOLD

Current Price

$5.17

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
DERM
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
135.3M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
QTRX
DERM
Price
$3.37
$5.17
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$6.00
$12.67
AVG Volume (30 Days)
877.3K
165.2K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.72
EPS
N/A
N/A
Revenue
$37,632,000.00
$61,858,000.00
Revenue This Year
$25.49
$39.72
Revenue Next Year
$10.04
$63.24
P/E Ratio
N/A
N/A
Revenue Growth
64.52
10.20
52 Week Low
$2.95
$4.31
52 Week High
$8.77
$9.56

Technical Indicators

Market Signals
Indicator
QTRX
DERM
Relative Strength Index (RSI) 44.04 42.16
Support Level $3.30 $4.31
Resistance Level $3.81 $5.50
Average True Range (ATR) 0.24 0.28
MACD 0.07 0.09
Stochastic Oscillator 54.25 38.00

Price Performance

Historical Comparison
QTRX
DERM

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: